Gsk Annual Results 2025 Calendar – Portfolio Receipts growth of 12% to $608 million; Royalty Receipts growth of 11%Net cash provided by operating activities of $658 millionRaising full year 2024 guidance: Portfolio Receipts expected to . Revenue saw a significant decline due to the conclusion of a discovery term with GSK. The company reported a total adjusted EBITDA deficit of $35 million. Improved metrics in membership revenue growth .

Gsk Annual Results 2025 Calendar

Source : www.gsk.com

EX 15.2

Source : www.sec.gov

Events calendar | GSK

Source : www.gsk.com

Academic Calendar – American University of Health Sciences

Source : www.auhs.edu

GSK delivers strong 2023 performance and upgrades growth outlooks

Source : www.gsk.com

Academic Calendar – American University of Health Sciences

Source : www.auhs.edu

Kristy Averette Research Practice Manager Duke University

Source : www.linkedin.com

Academic Calendar – American University of Health Sciences

Source : www.auhs.edu

Dividend calendar | GSK

Source : www.gsk.com

GSK Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Source : finance.yahoo.com

Gsk Annual Results 2025 Calendar Events calendar | GSK: UK house builder Bellway on Friday said it expected to return to growth in fiscal 2025 if market conditions remain stable Georgia-based TBC Bank reported robust second-quarter and first-half . Wall Street strategists advise investors to brace for more volatility ahead. .